Actinic keratoses, actinic field change and associations with squamous cell carcinoma in renal transplant recipients in Manchester, UK

Acta Dermato-Venereologica

Volumn 95, Issue 7, 2015, Pages 830-834

  Wallingford, Sarah C ^a   Russell, Sheila A ^b   Vail, Andy ^a   Proby, Charlotte M ^c   Lear, John T ^a,b   Green, Adèle C ^a,d  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

^d QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Actinic field change; Actinic keratosis; Immunosuppression; Renal transplant recipients; Squamous cell carcinoma

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; MYCOPHENOLATE MOFETIL; MYCOPHENOLIC ACID; PREDNISOLONE; RAPAMYCIN; TACROLIMUS;

ACTINIC FIELD CHANGE; ACTINIC KERATOSIS; ADULT; ARTICLE; BASAL CELL CARCINOMA; CANCER RISK; CUTANEOUS PARAMETERS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HOSPITAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREVALENCE; PRIORITY JOURNAL; SKIN; SKIN CARCINOMA; SKIN EXAMINATION; UNITED KINGDOM; ADOLESCENT; ADVERSE EFFECTS; CARCINOMA, SQUAMOUS CELL; CLINICAL TRIAL; ENGLAND; KERATOSIS, ACTINIC; MULTICENTER STUDY; PATHOLOGY; RISK ASSESSMENT; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SKIN NEOPLASMS; TIME FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; CARCINOMA, SQUAMOUS CELL; ENGLAND; FEMALE; HUMANS; KERATOSIS, ACTINIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SKIN; SKIN NEOPLASMS; TIME FACTORS; TRANSPLANT RECIPIENTS; YOUNG ADULT;

EID: 84940051830     PISSN: 00015555     EISSN: 16512057     Source Type: Journal    
DOI: 10.2340/00015555-2098     Document Type: Article

References (24)

1. Berg D, Otley CC. Skin cancer in organ transplant recipients: Epidemiology, pathogenesis, and management. J Am Acad Dermatol 2002; 47: 1–20.
2. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003; 348: 1681–1691.
3. Harwood CA, Mesher D, McGregor JM, Mitchell L, Green ML, Rafterty M, et al. A surveillence model for skin cancer in organ transplant recipients: A 22-year prospective study in an ethnically diverse population. Am J Transplant 2013; 13: 119–129.
4. Bouwes Bavinck JN, Euvrard S, Naldi L, Nindl I, Proby CM, Neale R, et al. Keratotic skin lesions and other risk factors are associated with skin cancer in organ-transplant recipients: A case-control study in the Netherlands, United Kingdom, Germany, France, and Italy. J Invest Dermatol 2007; 127: 1647–1656.
5. Keller B, Braathen L, Marti H, Hunger R. Skin cancers in renal transplant recipients: a description of the renal transplant cohort in Bern. Swiss Med Wkly 2010; 140: w13036.
6. Ramsay HM, Fryer AA, Reece S, Smith AG, Harden PN. Clinical risk factors associated with nonmelanoma skin cancer in renal transplant recipients. Am J Kidney Dis 2000; 36: 167–176.
7. Green A, Battistutta D. Incidence and determinants of skin cancer in a high-risk Australian population. Int J Cancer 1990; 46: 356–361.
8. Werner R, Sammain A, Erdmann R, Hartmann V, Stockfleth E, Nast A. The natural history of actinic keratosis: A systematic review. Br J Dermatol 2013; 169: 502–518.
9. Dodds A, Chia A, Shumack S. Actinic keratosis: rationale and management. Dermatol Therapy 2014; 4: 11–31.
10. Malvehy J. A new vision of actinic keratosis beyond clinical lesions. J Eur Acad Dermatol Venereol 2015; Supp 1: 3–8.
11. Slaughter DP, Southwick HW, Smejkal W. “Field cancerization” in oral stratified squamous epithelium. Clinical implications of multicentric origin. Cancer 1953; 6: 963–968.
12. Stockfleth E, Ferrandiz C, Grob JJ, Leigh I, Pehamberger H, Kerl H. Development of a treatment algorithm for actinic keratoses: a European Consensus. Eur J Dermatol 2008; 18: 651–659.
13. Szeimies R, Torezan L, Niwa A, Valente N, Unger P, Kohl E, et al. Clinical, histopathological and immunohistochemical assessment of human skin field cancerization before and after photodynamic therapy. Br J Dermatol 2012; 167: 150–159.
14. Braakhuis BJM, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH. A genetic explanation of Slaughter’s concept of field cancerization: Evidence and clinical implications. Cancer Res 2003; 63: 1727–1730.
15. Darlington S, Williams G, Neale R, Frost C, Green A. A randomized controlled trial to assess sunscreen application and beta carotene supplementation in the prevention of solar keratoses. Arch Dermatol 2003; 139: 451–455.
16. Armstrong BK, Kricker A. The epidemiology of UV induced skin cancer. J Photochem Photobiol B: Biol 2001; 6: 8–18.
17. Matin R, Gaunt P, McCartney D, Ismail F, Bowden S, McGregor J, et al. Developing a standardized actinic keratosis assessment protocol. In: British Association of Dermatologists 93rd Annual Meeting (British Society for Skin Cancer in Immunocompromised Individuals, editors). Liverpool, UK. Br J Dermatol 2013; 169: 99–111.
18. Rüdlinger R, Smith IW, Bunney MH, Hunter JAA. Human papillomavirus infections in a group of renal transplant recipients. Br J Dermatol 1986; 115: 681–692.
19. Bouwes Bavinck JN, Boer AD, Vermeer BJ, Hartevelt MM, Woude FJVD, Claas FHJ, et al. Sunlight, keratotic skin lesions and skin cancer in renal transplant recipients. Br J Dermatol 1993; 129: 242–249.
20. Criscione VD, Weinstock MA, Naylor MF, Luque C, Elde MJ, Bingham SF. Actinic keratoses. Natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial. Cancer 2009; 115: 2523–2530.
21. Garcia JB, Suárez-Varela MM, Vilata JJ, Marquina A, Pallard L, Crespo J. Risk factors for non-melanoma skin cancer in kidney transplant patients in a Spanish population in the Mediterranean region. Acta Derm Venereol 2013; 93: 422–427.
22. Harwood C, Surentheran T, McGregor J, Spink P, Leigh I, Breuer J, et al. Human papillomavirus infection and nonmelanoma skin cancer in immunosuppressed and immunocompetent individuals. J Med Virol 2000; 61: 289–297.
23. Mittelbronn MA, Mullins DL, Ramos-Caro FA, Flowers FP. Frequency of pre-existing actinic keratosis in cutaneous squamous cell carcinoma. Int J Dermatol 2002; 37: 677–681.
24. Ramsay HM, Fryer AA, Hawley CM, Smith AG, Nicol DL, Harden PN. Non-melanoma skin cancer risk in the Queensland renal transplant population. Br J Dermatol 2002; 147: 950–956.